Logan Capital Management Inc. Has $14.04 Million Position in Waters Co. (NYSE:WAT)

Logan Capital Management Inc. lessened its stake in shares of Waters Co. (NYSE:WAT) by 1.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 39,014 shares of the medical instruments supplier’s stock after selling 498 shares during the quarter. Logan Capital Management Inc.’s holdings in Waters were worth $14,041,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of WAT. Kennebec Savings Bank acquired a new position in shares of Waters during the 3rd quarter worth about $33,000. Ashton Thomas Securities LLC bought a new position in Waters in the 3rd quarter worth approximately $35,000. Itau Unibanco Holding S.A. acquired a new position in shares of Waters during the second quarter worth approximately $33,000. Blue Trust Inc. boosted its position in shares of Waters by 190.2% in the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 78 shares during the period. Finally, TFC Financial Management Inc. increased its position in Waters by 19,900.0% during the second quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after acquiring an additional 199 shares during the period. Institutional investors own 94.01% of the company’s stock.

Waters Price Performance

WAT stock traded down $4.44 during trading on Friday, hitting $378.59. 18,780 shares of the stock traded hands, compared to its average volume of 438,736. The stock has a market cap of $22.48 billion, a price-to-earnings ratio of 36.51, a P/E/G ratio of 7.05 and a beta of 1.01. Waters Co. has a one year low of $279.24 and a one year high of $397.02. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The company has a 50 day simple moving average of $365.52 and a 200 day simple moving average of $335.79.

Waters (NYSE:WAT) last posted its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The company had revenue of $740.30 million during the quarter, compared to analysts’ expectations of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. Waters’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.84 earnings per share. Equities analysts expect that Waters Co. will post 11.79 EPS for the current fiscal year.

Analysts Set New Price Targets

WAT has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft increased their price target on shares of Waters from $310.00 to $325.00 and gave the company a “hold” rating in a report on Monday, November 4th. Cfra set a $389.00 target price on shares of Waters in a research note on Thursday, October 17th. Sanford C. Bernstein upped their price target on Waters from $345.00 to $360.00 and gave the company a “market perform” rating in a report on Monday, November 4th. TD Cowen raised their price objective on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Finally, JPMorgan Chase & Co. boosted their price objective on Waters from $340.00 to $380.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $371.33.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.